Nicotinamide/ja

Nicotinamide/ja

Clinical data
Pronunciation	/ˌnaɪəˈsɪnəmaɪd/, /ˌnɪkəˈtɪnəmaɪd/
Other names	NAM, 3-pyridinecarboxamide niacinamide nicotinic acid amide vitamin PP nicotinic amide vitamin B3
AHFS/Drugs.com	Consumer Drug Information
License data	US DailyMed: Niacinamide
Routes of administration	By mouth, topical
ATC code	A11HA01 (WHO)
Legal status
Legal status	US: OTC
Identifiers
IUPAC name pyridine-3-carboxamide
CAS Number	98-92-0  Y
PubChem CID	936
DrugBank	DB02701
ChemSpider	911
UNII	25X51I8RD4
KEGG	D00036
ChEBI	CHEBI:17154
ChEMBL	ChEMBL1140
Chemical and physical data
Formula	C6H6N2O
Molar mass	122.127 g·mol−1
3D model (JSmol)	Interactive image
Density	1.40 g/cm3 g/cm3
Melting point	129.5 °C (265.1 °F)
Boiling point	334 °C (633 °F)
SMILES c1cc(cnc1)C(=O)N
InChI InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9) Key:DFPAKSUCGFBDDF-UHFFFAOYSA-N

ナイアシンアミド（Niacinamide）またはニコチンアミド（nicotinamide）は、食品に含まれるビタミンB₃の一種であり、栄養補助食品や医薬品として用いられる。サプリメントとしては、ペラグラ（ナイアシン欠乏症）を予防・治療するために経口で使用される。この目的にはニコチン酸（ナイアシン）が使用されることもあるが、ナイアシンアミドは皮膚潮紅を引き起こさないという利点がある。クリームとしてはにきびの治療に使用され、臨床研究では色素沈着や赤みを抑えることで老化した肌の見た目を改善することが確認されている。水溶性ビタミンである。ナイアシンアミドはサプリメント名であり、ニコチンアミドは学名である。

副作用はほとんどない。高用量では肝障害が起こることがある。通常量は妊娠中の使用にも安全である。ナイアシンアミドはビタミンB系列の医薬品、特にビタミンB₃複合体に属する。ニコチン酸のアミドである。ナイアシンアミドを含む食品には、酵母、肉、牛乳、緑黄色野菜などがある。

Niacinamide was discovered between 1935 and 1937. It is on the World Health Organization's List of Essential Medicines. Niacinamide is available as a generic medication and over the counter. Commercially, niacinamide is made from either nicotinic acid (niacin) or nicotinonitrile. In some countries, grains have niacinamide added to them.

Medical uses

Niacin deficiency

Niacinamide is the preferred treatment for pellagra, caused by niacin deficiency.

Acne

Niacinamide cream is used as a treatment for acne.

Niacinamide increases the biosynthesis of ceramides in human keratinocytes in vitro and improves the epidermal permeability barrier in vivo. The application of 2% topical niacinamide for 2 and 4 weeks has been found to be effective in lowering the sebum excretion rate. Niacinamide has been shown to prevent Cutibacterium acnes-induced activation of toll-like receptor 2, which ultimately results in the down-regulation of pro-inflammatory interleukin-8 production.

Skin cancer

Niacinamide at doses of 500 to 1000 mg a day decreases the risk of skin cancers, other than melanoma, in those at high risk.

Side effects

Niacinamide has minimal side effects. At very high doses above 3g/ day acute liver toxicity has been documented in at least one case. Normal doses are safe during pregnancy.

Chemistry

The structure of nicotinamide consists of a pyridine ring to which a primary amide group is attached in the meta position. It is an amide of nicotinic acid. As an aromatic compound, it undergoes electrophilic substitution reactions and transformations of its two functional groups. Examples of these reactions reported in Organic Syntheses include the preparation of 2-chloronicotinonitrile by a two-step process via the N-oxide,

from nicotinonitrile by reaction with phosphorus pentoxide, and from 3-aminopyridine by reaction with a solution of sodium hypobromite, prepared in situ from bromine and sodium hydroxide.

NAD⁺, the oxidized form of NADH, contains the nicotinamide moiety (highlighted in red)

Industrial production

The hydrolysis of nicotinonitrile is catalysed by the enzyme nitrile hydratase from Rhodococcus rhodochrous J1, producing 3500 tons per annum of nicotinamide for use in animal feed. The enzyme allows for a more selective synthesis as further hydrolysis of the amide to nicotinic acid is avoided. Nicotinamide can also be made from nicotinic acid. According to Ullmann's Encyclopedia of Industrial Chemistry, worldwide 31,000 tons of nicotinamide were sold in 2014.

Biochemistry

The active Nicotinamide group on the molecule NAD⁺ undergoes oxidation in many metabolic pathways.

Nicotinamide, as a part of the cofactor nicotinamide adenine dinucleotide (NADH / NAD⁺) is crucial to life. In cells, nicotinamide is incorporated into NAD⁺ and nicotinamide adenine dinucleotide phosphate (NADP⁺). NAD⁺ and NADP⁺ are cofactors in a wide variety of enzymatic oxidation-reduction reactions, most notably glycolysis, the citric acid cycle, and the electron transport chain. If humans ingest nicotinamide, it will likely undergo a series of reactions that transform it into NAD, which can then undergo a transformation to form NADP⁺. This method of creation of NAD⁺ is called a salvage pathway. However, the human body can produce NAD⁺ from the amino acid tryptophan and niacin without our ingestion of nicotinamide.

NAD⁺ acts as an electron carrier that mediates the interconversion of energy between nutrients and the cell's energy currency, adenosine triphosphate (ATP). In oxidation-reduction reactions, the active part of the cofactor is the nicotinamide. In NAD⁺, the nitrogen in the aromatic nicotinamide ring is covalently bonded to adenine dinucleotide. The formal charge on the nitrogen is stabilized by the shared electrons of the other carbon atoms in the aromatic ring. When a hydride atom is added onto NAD⁺ to form NADH, the molecule loses its aromaticity, and therefore a good amount of stability. This higher energy product later releases its energy with the release of a hydride, and in the case of the electron transport chain, it assists in forming adenosine triphosphate.

When one mole of NADH is oxidized, 158.2 kJ of energy will be released.

Biological role

Nicotinamide occurs as a component of a variety of biological systems, including within the vitamin B family and specifically the vitamin B₃ complex. It is also a critically important part of the structures of NADH and NAD⁺, where the N-substituted aromatic ring in the oxidised NAD⁺ form undergoes reduction with hydride attack to form NADH. The NADPH/NADP⁺ structures have the same ring, and are involved in similar biochemical reactions.

Nicotinamide can be methylated in the liver to biologically active 1-Methylnicotinamide when there are sufficient methyl donors.

Food sources

Niacinamide occurs in trace amounts mainly in meat, fish, nuts, and mushrooms, as well as to a lesser extent in some vegetables. It is commonly added to cereals and other foods. Many multivitamins contain 20–30 mg of vitamin B₃ and it is also available in higher doses.

Compendial status

• British Pharmacopoeia
• Japanese Pharmacopoeia

Research

A 2015 trial found niacinamide to reduce the rate of new nonmelanoma skin cancers and actinic keratoses in a group of people at high risk for the conditions.

Niacinamide has been investigated for many additional disorders, including treatment of bullous pemphigoid nonmelanoma skin cancers.

Niacinamide may be beneficial in treating psoriasis.

There is tentative evidence for a potential role of niacinamide in treating acne, rosacea, autoimmune blistering disorders, ageing skin, and atopic dermatitis. Niacinamide also inhibits poly(ADP-ribose) polymerases (PARP-1), enzymes involved in the rejoining of DNA strand breaks induced by radiation or chemotherapy. ARCON (accelerated radiotherapy plus carbogen inhalation and nicotinamide) has been studied in cancer.

Research has suggested niacinamide may play a role in the treatment of HIV.